Then my guess is everyone will be talking taxes. Have not looked into it yet but I'm thinking a combo of shares and cash would be the way to go. Or even all shares.
You forget who they are dealing with. Linda knows the value of what she holds and is not going to hand off intrinsic value to someone with cash to offer to clueless retail traders and longs looking for a quick $. She has waited this long for approval and she will wait a little longer for tissue agnostic designation and Direct value. No way she just hands that off to big pharma after all they have gone through. Based on your numbers, you don’t know Linda very well and she is obviously a much better negotiator and able to wait longer than you ; ). Best wishes.
News 
Market Data 
Discover 
